Product Code: ETC312100 | Publication Date: Aug 2022 | Updated Date: Feb 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
United Arab Emirates (UAE) Aminoglycosides market currently, in 2023, has witnessed an HHI of 2055, Which has decreased slightly as compared to the HHI of 2351 in 2017. The market is moving towards moderately competitive. Herfindahl index measures the competitiveness of exporting countries. The range lies from 0 to 10000, where a lower index number represents a larger number of players or exporting countries in the market while a large index number means fewer numbers of players or countries exporting in the market.
The UAE Aminoglycosides market is a critical segment within the pharmaceutical industry, contributing significantly to antimicrobial therapy. These broad-spectrum antibiotics play a pivotal role in treating severe bacterial infections. Market dynamics are influenced by factors such as advancements in drug formulation, emergence of antibiotic-resistant strains, and regulatory guidelines governing their use.
The UAE Aminoglycosides market is driven by the rising incidence of bacterial infections and the need for effective antibiotics in the healthcare sector. Aminoglycosides are known for their potency against a wide range of gram-negative bacteria, making them essential in critical care settings. Moreover, ongoing research and development efforts to enhance the efficacy and reduce side effects of aminoglycosides contribute to market expansion.
The UAE Aminoglycosides market faces regulatory hurdles as strict government regulations and quality control standards impact product approval and market access. Additionally, rising concerns about antibiotic resistance require constant research and development efforts to innovate new aminoglycoside compounds while ensuring their safety and efficacy.
The UAE aminoglycosides market was impacted by the COVID-19 pandemic, with fluctuations in demand from healthcare facilities. Supply chain disruptions and concerns over antibiotic use added complexity to the market. As healthcare services return to normalcy, the market is expected to regain stability.
The UAE Aminoglycosides market is a pivotal segment within the pharmaceutical industry, characterized by a robust demand for antibiotics known for their efficacy against a wide range of bacterial infections. Key players in this market include reputable pharmaceutical companies such as Pfizer, Novartis, and GlaxoSmithKline. These industry giants have established themselves as leaders in producing high-quality aminoglycoside antibiotics, providing healthcare professionals in the UAE with essential tools to combat infectious diseases.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Aminoglycosides Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Aminoglycosides Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Aminoglycosides Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United Arab Emirates (UAE) Aminoglycosides Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Arab Emirates (UAE) Aminoglycosides Market Trends |
6 United Arab Emirates (UAE) Aminoglycosides Market, By Types |
6.1 United Arab Emirates (UAE) Aminoglycosides Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Neomycin, 2021-2031F |
6.1.4 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Tobramycin, 2021-2031F |
6.1.5 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Gentamicin, 2021-2031F |
6.1.6 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Amikacin, 2021-2031F |
6.1.7 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Paromomycin, 2021-2031F |
6.1.8 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Streptomycin, 2021-2031F |
6.1.9 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.2 United Arab Emirates (UAE) Aminoglycosides Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Injectables (Parenteral), 2021-2031F |
6.2.3 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Feed, 2021-2031F |
6.2.4 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Intra-mammary, 2021-2031F |
6.2.5 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Topical, 2021-2031F |
6.2.6 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Oral, 2021-2031F |
6.3 United Arab Emirates (UAE) Aminoglycosides Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Veterinary, 2021-2031F |
6.3.3 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Skin Infection, 2021-2031F |
6.3.4 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Respiratory diseases, 2021-2031F |
6.3.5 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By UTI & Pelvic Diseases, 2021-2031F |
6.3.6 United Arab Emirates (UAE) Aminoglycosides Market Revenues & Volume, By Other diseases, 2021-2031F |
7 United Arab Emirates (UAE) Aminoglycosides Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Aminoglycosides Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Aminoglycosides Market Imports from Major Countries |
8 United Arab Emirates (UAE) Aminoglycosides Market Key Performance Indicators |
9 United Arab Emirates (UAE) Aminoglycosides Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Aminoglycosides Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Aminoglycosides Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Aminoglycosides Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United Arab Emirates (UAE) Aminoglycosides Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Aminoglycosides Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Aminoglycosides Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |